The Hindu Business Line : Accutest Labs expands clinical research

Ahmedabad, Oct. 23 The New Mumbai-based Accutest Research Laboratories, a full-service clinical research organisation (CRO), on Tuesday inaugurated its second facility for clinical trial here with an investment of Rs seven crore.

Accutest, the first in India to have multi-locational independent branches, has clients from India, US, Europe, South Africa and Japan, Dr Nirav Gandhi, Vice-President, told reporters.

The company, whose core strength lies in bioequivalence/bioavailability, pharmacokinetic studies and formulation development, has so far invested Rs 22 crore in its two units in Ahmedabad, he said. It is the first centre in India to have API-5000 LCMS/MS machines for research. The existing centres at Ahmedabad have been successfully audited by USFDA and WHO.

CRO Market

“The CRO market in India is expected to cross the $1 billion mark by 2010 as compared to $200 million in 2006, experiencing almost 50 per cent growth every year. There is a huge potential untapped as India currently accounts for less than five per cent of global clinical trials. As Gujarat has the maximum number of pharmaceutical manufacturing units, Accutest aims to capture a large share of the CRO market by 2010 through its Gujarat operations,” said Dr Santosh Joshi, COO and Director.

Accutest has grown almost 60 per cent every year since the last three years and expects to continue the trend for the next three years. “We are expecting to be amongst top three CROs in India and a significant global player by 2010,” Dr Satish Sawant, CEO, said.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Accutest Labs expands clinical research

Cookson Electronics opens R&D centre in Bangalore

Korean co to make set-top boxes for Tata Sky

Norms issued for stock options valuation

HC to hear Glivec issue on Nov 6

Suzlon Energy: Making up for last quarter

Patent for 3 Suven products

Sujana Towers debentures

GMR’s verticals to have brand identities of their own

Corporate governance: Survey lists pros and cons of family owned cos

GM setting up facility for powertrains

USFDA nod for Sun Pharma drug

ITC signs MoU with Nagaland, Spices Board

GVFL invests Rs 4 cr in Sahajanand Laser Tech

Subhkam invests in MSK Projects

Continental taps Siemens VDO to make India its strategic hub

Ashok Leyland reports modest sales figures; net dips 16%